Stryker Corporation Declares Quarterly Dividend of $0.88 (NYSE:SYK)

Stryker Corporation (NYSE:SYK) declared a quarterly dividend on Tuesday, August 4th. Stockholders of record on Wednesday, September 30th will be paid a dividend of 0.88 per share by the medical technology company on Friday, October 30th. This represents a c) annualized dividend and a dividend yield of 1.0%. The ex-dividend date is Wednesday, September 30th.

Stryker has increased its dividend by an average of 0.1%per year over the last three years and has raised its dividend every year for the last 32 years. Stryker has a dividend payout ratio of 23.7% indicating that its dividend is sufficiently covered by earnings. Analysts expect Stryker to earn $16.75 per share next year, which means the company should continue to be able to cover its $3.52 annual dividend with an expected future payout ratio of 21.0%.

Stryker Price Performance

Shares of Stryker stock traded up $0.04 on Thursday, reaching $337.07. 125,048 shares of the stock were exchanged, compared to its average volume of 2,368,360. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.33 and a current ratio of 2.16. The firm has a market cap of $129.29 billion, a PE ratio of 34.93, a P/E/G ratio of 2.14 and a beta of 0.76. The firm’s 50 day moving average is $318.85 and its 200-day moving average is $334.29. Stryker has a one year low of $281.00 and a one year high of $396.86.

Stryker (NYSE:SYK) last announced its quarterly earnings data on Thursday, July 30th. The medical technology company reported $3.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.49 by $0.20. Stryker had a net margin of 14.43% and a return on equity of 23.63%. The business had revenue of $6.59 billion for the quarter, compared to analysts’ expectations of $6.58 billion. During the same period last year, the firm posted $3.13 earnings per share. The firm’s quarterly revenue was up 9.4% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. As a group, analysts anticipate that Stryker will post 15.02 EPS for the current fiscal year.

Insider Transactions at Stryker

In other news, VP Robert S. Fletcher sold 4,544 shares of Stryker stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $306.87, for a total value of $1,394,417.28. Following the completion of the sale, the vice president owned 10,582 shares in the company, valued at $3,247,298.34. The trade was a 30.04% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Ronda E. Stryker sold 310,000 shares of the stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $312.23, for a total transaction of $96,791,300.00. Following the transaction, the director directly owned 1,924,880 shares in the company, valued at approximately $601,005,282.40. This represents a 13.87% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 323,264 shares of company stock valued at $100,659,489 in the last quarter. 4.60% of the stock is currently owned by company insiders.

Institutional Trading of Stryker

Large investors have recently made changes to their positions in the company. Brighton Jones LLC lifted its holdings in shares of Stryker by 15.4% in the 4th quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company’s stock worth $1,643,000 after purchasing an additional 609 shares in the last quarter. Schnieders Capital Management LLC. bought a new stake in Stryker during the 2nd quarter valued at $205,000. Marshall Wace LLP raised its holdings in Stryker by 107.9% during the second quarter. Marshall Wace LLP now owns 5,700 shares of the medical technology company’s stock worth $2,255,000 after buying an additional 77,831 shares during the last quarter. Nebula Research & Development LLC bought a new position in shares of Stryker in the second quarter valued at $219,000. Finally, HUB Investment Partners LLC acquired a new position in shares of Stryker during the second quarter valued at about $253,000. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.